MASS Share Price Performance
US$7.32
2.87 (64.49%)
26.8% undervalued intrinsic discount
US$10.00
Fair Value
Price US$7.32
AnalystConsensusTarget US$10.00
AnalystLowTarget US$8.00
AnalystHighTarget US$12.00
Fair ValueUS$10.00
Share Pricen/a
908 Devices Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
MASS Community Narratives
AN
Fair Value US$10 26.8% undervalued intrinsic discount
US Federal And International Funding Will Expand Global Analysis Markets
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value US$8 8.5% undervalued intrinsic discount
US And NATO Shifts Will Cripple Demand But Open Opportunities
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$12 39.0% undervalued intrinsic discount
Decentralized Diagnostics And Global Security Will Expand Analytical Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US And NATO Shifts Will Cripple Demand But Open Opportunities
Key Takeaways Heavy reliance on government budgets and limited product platforms creates revenue risks amid uncertain policy shifts and technological change. Slower product adoption, ongoing regulatory pressures, and competitive innovation may hinder margin expansion and consistent long-term growth.Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$8
8.5% undervalued intrinsic discount
Fair Value
Profit Margin
9.04%
Future PE
55.31x
Price in 2028
US$10.07
Decentralized Diagnostics And Global Security Will Expand Analytical Markets
Key Takeaways Expansion into new healthcare and biopharma markets, along with increased law enforcement demand, could significantly accelerate recurring revenue and sustained multi-vertical earnings growth. Enhanced software integration, manufacturing control, and AI-driven analytics position the company for higher margins, strong pricing power, and new B2B revenue opportunities.Read more
4
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$12
39.0% undervalued intrinsic discount
Fair Value
Profit Margin
9.04%
Future PE
83.07x
Price in 2028
US$15.14
US Federal And International Funding Will Expand Global Analysis Markets
Key Takeaways Expanding public and private sector funding, along with strong global demand, positions the company for accelerated growth and increased market share in molecular analysis devices. Operational improvements and a shift toward recurring revenue streams are expected to enhance margins, earnings stability, and reduce financial risk.Read more
22
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
US$10
26.8% undervalued intrinsic discount
Fair Value
Profit Margin
9.04%
Future PE
72.07x
Price in 2028
US$12.59
Trending Discussion
Recently Updated Narratives
AN
US And NATO Shifts Will Cripple Demand But Open Opportunities
Fair Value: US$8 8.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Decentralized Diagnostics And Global Security Will Expand Analytical Markets
Fair Value: US$12 39.0% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
US Federal And International Funding Will Expand Global Analysis Markets
Fair Value: US$10 26.8% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
908 Devices Inc. Key Details
About MASS
- Founded
- 2012
- Employees
- 172
- CEO
- WebsiteView website
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
